Ifg Advisory, LLC Sorrento Therapeutics, Inc. Transaction History

Ifg Advisory, LLC

  • $1.54 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
SELL
$0.74 - $1.83 $28 - $71
-39 Reduced 0.19%
20,000 $17,000
Q3 2022

Oct 28, 2022
BUY
$1.51 - $2.88 $58 - $112
39 Added 0.19%
20,039 $31,000
Q1 2022

May 04, 2022
BUY
$2.0 - $4.9 $8,200 - $20,090
4,100 Added 25.79%
20,000 $46,000
Q4 2021

Feb 14, 2022
SELL
$4.65 - $7.23 $9,300 - $14,460
-2,000 Reduced 11.17%
15,900 $73,000
Q3 2021

Oct 12, 2021
BUY
$7.41 - $10.99 $132,639 - $196,721
17,900 New
17,900 $136,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Ifg Advisory, LLC Portfolio

Follow Ifg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email